Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolus, Inc.EOLS · Entity 5341 | See Remarks | March 20, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolus, Inc.
Report date March 20, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 427,423 |
Reported balance
After 2026-03-20 transaction · row 1
1 source rowRow 1 · 2026-03-20 · Sale · Disposed 3,119 · Balance 427,423 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards. F2: The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.
F2: The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2026 Filed Mar 20, 2026 23:19 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 3,119 | $4.75 | $14,815.25 |
DisclosureSEC source: 0001570562-26-000050 · wk-form4_1774048743.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427,423 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards. F2 · price: The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 00:00 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 29,996 | $4.89 | $146,629.45 |
DisclosureSEC source: 0001570562-26-000045 · wk-form4_1773878429.xml · nonDerivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 430,542 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of multiple PSU and restricted stock unit awards. F3 · price: The shares were sold in multiple trades at prices ranging from $4.8874 to $4.945. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2026 Filed Mar 19, 2026 00:00 UTC | Evolus, Inc. EOLS · Entity 5341 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 8,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-26-000045 · wk-form4_1773878429.xml · derivative · entry 3 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,802 Underlying: Common Stock · 8,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. F1 · kind: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. F1 · derivative.exercise_date: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. F1 · derivative.expiration_date: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. Read SEC document |
| March 16, 2026 Filed Mar 19, 2026 00:00 UTC | Evolus, Inc. EOLS · Entity 5341 | Exercise / conversionCommon Stock | 8,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-26-000045 · wk-form4_1773878429.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 460,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:57 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 138,649 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001570562-26-000021 · wk-form4_1771552634.xml · derivative · entry 3 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,649 Underlying: Common Stock · 138,649 shares Expires 2036-02-17 F4 · derivative.exercise_date: The shares subject to the option vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:57 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantPerformance Restricted Stock Units · Derivative | 94,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-26-000021 · wk-form4_1771552634.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,913 Underlying: Common Stock · 94,913 shares Expires not disclosed F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs. F3 · derivative.exercise_date: The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period. F3 · derivative.expiration_date: The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:57 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 94,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-26-000021 · wk-form4_1771552634.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,734 F1 · shares: Represents shares issuable upon settlement of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 23:42 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 2,261 | $7.15 | $16,167.73 |
DisclosureSEC source: 0001570562-25-000118 · wk-form4_1767051717.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 356,821 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units. Read SEC document |
| May 12, 2025 Filed May 14, 2025 23:27 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 3,385 | $9.87 | $33,396.75 |
DisclosureSEC source: 0001570562-25-000081 · wk-form4_1747265264.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 359,082 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 22:27 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 27,904 | $13.26 | $369,867.52 |
DisclosureSEC source: 0001570562-25-000054 · wk-form4_1742509649.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 362,467 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $13.174 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:54 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 33,875 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0001570562-25-000041 · wk-form4_1741733665.xml · derivative · entry 3 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,875 Underlying: Common Stock · 33,875 shares Expires 2035-03-07 F4 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:54 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantPerformance Restricted Stock Units · Derivative | 23,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-25-000041 · wk-form4_1741733665.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,776 Underlying: Common Stock · 23,776 shares Expires not disclosed F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs. F3 · derivative.exercise_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates. F3 · derivative.expiration_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:54 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 23,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-25-000041 · wk-form4_1741733665.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,371 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 22:28 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 2,252 | $10.85 | $24,438.48 |
DisclosureSEC source: 0001570562-24-000140 · wk-form4_1735252102.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 366,595 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 10, 2024 Filed May 15, 2024 00:56 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 3,441 | $12.72 | $43,760.57 |
DisclosureSEC source: 0001570562-24-000085 · wk-form4_1715734552.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,847 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: The shares were sold in multiple trades at prices ranging from $12.51 to $13.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 22:09 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 27,603 | $13.92 | $384,349.69 |
DisclosureSEC source: 0001570562-24-000055 · wk-form4_1711058963.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,288 F1 · kind: The sales reported on this Form 4 were mandated by the Issuer pursuant to Restricted Stock Unit Agreements requiring the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction, and does not represent a discretionary trade by the reporting person. F2 · price: The shares were sold in multiple trades at prices ranging from $13.555 to $14.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 22, 2024 Filed Feb 24, 2024 01:27 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 1,821 | $13.08 | $23,820.87 |
DisclosureSEC source: 0001570562-24-000030 · wk-form4_1708738054.xml · nonDerivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 399,891 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the PSUs. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:27 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 13,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-24-000030 · wk-form4_1708738054.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 401,712 F1 · shares: Represents shares issuable on settlement of performance restricted stock units ("PSUs") granted to the reporting person in January 2023. The Issuer's Compensation Committee certified that the reporting person had achieved the set corporate development goal as of December 20, 2023. One-third of the PSU (4,372 shares) was delivered on February 21, 2024 after certification of the milestone being achieved. The remaining two-thirds will vest annually on the anniversary of December 20, 2023 provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:36 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 47,337 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001570562-24-000017 · wk-form4_1707521755.xml · derivative · entry 3 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,337 Underlying: Common Stock · 47,337 shares Expires 2034-02-07 F4 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:36 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantPerformance Restricted Stock Units · Derivative | 17,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-24-000017 · wk-form4_1707521755.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,606 Underlying: Common Stock · 17,606 shares Expires not disclosed F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs. F3 · derivative.exercise_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 50% of the PSUs earned will vest on February 7, 2026 and the remaining 50% of the PSUs will vest on February 7, 2027, in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates. F3 · derivative.expiration_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 50% of the PSUs earned will vest on February 7, 2026 and the remaining 50% of the PSUs will vest on February 7, 2027, in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:36 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 35,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-24-000017 · wk-form4_1707521755.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,597 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 00:25 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 2,211 | $10.27 | $22,706.97 |
DisclosureSEC source: 0001570562-23-000100 · wk-form4_1692231941.xml · nonDerivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 353,386 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the PSUs. Read SEC document |
| August 14, 2023 Filed Aug 17, 2023 00:25 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 19,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-23-000100 · wk-form4_1692231941.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,597 F1 · shares: Represents shares issuable on settlement of performance restricted stock units ("PSUs") granted to the reporting person in January 2023. On August 14, 2023, the Issuer's Compensation Committee certified that the reporting person had achieved the set corporate development goal as of May 9, 2023. One-third of the PSU (6,557 shares) was vested and delivered immediately upon certification of the goal achievement. The remaining two-thirds will vest annually on the anniversary of May 9, 2023 provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 23:01 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 14,906 | $8.47 | $126,237.42 |
DisclosureSEC source: 0001570562-23-000045 · wf-form4_167900769866882.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,925 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $8.25 to $8.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 00:25 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 85,670 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001570562-23-000012 · wf-form4_167486549856245.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,670 Underlying: Common Stock · 85,670 shares Expires 2033-01-25 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 00:25 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 97,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-23-000012 · wf-form4_167486549856245.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,831 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:23 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 10,192 | $9.73 | $99,121.28 |
DisclosureSEC source: 0001570562-22-000084 · wf-form4_164695819801702.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,189 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 02:02 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 77,640 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001570562-22-000053 · wf-form4_164324895584499.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,640 Underlying: Common Stock · 77,640 shares Expires 2032-01-25 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 02:02 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 53,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-22-000053 · wf-form4_164324895584499.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,381 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 22:45 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 14,293 | $11.18 | $159,788.59 |
DisclosureSEC source: 0001570562-21-000155 · wf-form4_162880829149055.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,810 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the second quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $11.1762 to $11.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 27, 2021 Filed Feb 2, 2021 00:29 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000018 · wf-form4_161222574461892.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,103 F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 01:50 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 2,699 | $7.46 | $20,134.54 |
DisclosureSEC source: 0001570562-21-000010 · wf-form4_161171222211564.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,103 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. Read SEC document |
| May 13, 2020 Filed May 16, 2020 00:00 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000094 · wf-form4_158958718809777.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,802 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:15 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000049 · wf-form4_157991848930412.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-01-23 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:15 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000049 · wf-form4_157991848930412.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,802 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 00:37 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 39,442 | $10.71 | $422,281.83 |
DisclosureSEC source: 0001570562-20-000002 · wf-form4_157853021770409.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,802 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the fourth quarter of 2019 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $10.68 to $11.2016. The price reported above reflects the weighted average selling price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 22:53 UTC | Evolus, Inc. EOLS · Entity 5341 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,020 | $0.00 Strike: $9.98 | $0.00 |
DisclosureSEC source: 0001570562-19-000164 · wf-form4_157610476734295.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,682 Underlying: Common Stock · 10,020 shares Expires 2028-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on January 6, 2018 for the right to buy 199,702 shares of common stock of the Issuer. The shares subject to the option vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 22:53 UTC | Evolus, Inc. EOLS · Entity 5341 | Exercise / conversionCommon Stock | 10,020 | $9.98 | $99,999.60 |
DisclosureSEC source: 0001570562-19-000164 · wf-form4_157610476734295.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2019 Filed Jan 26, 2019 01:22 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $16.19 | $0.00 |
DisclosureSEC source: 0001570562-19-000026 · wf-form4_154846575247503.xml · derivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.